(FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q9)Sep 30, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 23.70%44.11B | 21.70%29.51B | 24.07%18.87B | 24.39%8.46B | 22.11%35.66B | 21.95%24.25B | 19.45%15.21B | 15.18%6.8B | 0.84%29.2B | -7.31%19.88B |
Operating income | 23.70%44.11B | 21.70%29.51B | 24.07%18.87B | 24.39%8.46B | 22.11%35.66B | 21.95%24.25B | 19.45%15.21B | 15.18%6.8B | 0.84%29.2B | -7.31%19.88B |
Operating expenses | -18.02%-24.73B | -20.22%-7.29B | -26.43%-20.95B | -14.36%-6.06B | 0.40%-16.57B | |||||
Gross profit | 45.12%4.78B | 58.86%1.17B | -0.51%3.29B | 22.44%733.65M | -31.20%3.31B | |||||
Selling expenses | ---- | 83.15%-3.87M | ---- | 85.61%-882.44K | ---- | -57.29%-22.97M | ---- | -45.11%-6.13M | ---- | 36.85%-14.61M |
Administrative expenses | ---- | -15.47%-611.12M | ---- | -31.66%-202.56M | ---- | -15.01%-529.22M | ---- | 2.37%-153.85M | ---- | 2.95%-460.15M |
Research and development expenses | ---- | -28.57%-809.01M | ---- | -23.73%-235.93M | ---- | 3.02%-629.25M | ---- | -5.60%-190.69M | ---- | -17.60%-648.84M |
Profit from asset sales | ---- | -17.10%479.05K | ---- | 593.99%212.69K | ---- | 120.70%577.86K | ---- | 95.93%-43.06K | ---- | -165.41%-2.79M |
Employee expense | -10.63%-8.2B | ---- | -15.73%-3.35B | ---- | -22.95%-7.41B | ---- | -16.81%-2.89B | ---- | -23.14%-6.03B | ---- |
Depreciation and amortization | -11.04%-5.61B | ---- | -6.79%-2.63B | ---- | -3.82%-5.05B | ---- | -3.13%-2.46B | ---- | -1.05%-4.87B | ---- |
Revaluation surplus | ---- | 9.41%62.58M | ---- | -14.50%33.23M | ---- | -3.42%57.19M | ---- | 6.08%38.87M | ---- | 400.85%59.22M |
-Changes in the fair value of other assets | ---- | 9.41%62.58M | ---- | -14.50%33.23M | ---- | -3.42%57.19M | ---- | 6.08%38.87M | ---- | 400.85%59.22M |
Impairment and provision | 28.95%-56.58M | -7.22%-22.5M | -27.71%-18.67M | 10.00%-9.48M | 96.07%-79.63M | 2.19%-20.99M | -481.42%-14.62M | -33.21%-10.53M | -39.26%-2.03B | 97.53%-21.46M |
-Impairment of property, machinery and equipment | ---- | ---- | ---- | ---- | 98.50%-30.2M | ---- | ---- | ---- | -38.92%-2.01B | ---- |
-Other impairment is provision | -14.45%-56.58M | -7.22%-22.5M | -27.71%-18.67M | 10.00%-9.48M | -213.71%-49.44M | 2.19%-20.99M | -481.42%-14.62M | -33.21%-10.53M | -102.60%-15.76M | 97.53%-21.46M |
Special items of operating profit | -24.47%-25.32B | -32.56%304.09M | -27.16%-10.89B | -49.82%117.01M | -38.34%-20.34B | 14.14%450.9M | -31.61%-8.56B | 32.49%233.17M | -7.99%-14.7B | -9.48%395.05M |
Operating profit | 78.28%4.86B | 42.34%3.66B | 55.46%1.97B | 34.76%861.1M | 76.69%2.72B | -0.83%2.57B | -6.38%1.27B | 40.13%639.01M | -62.79%1.54B | -21.93%2.6B |
Financing income | 46.75%181.13M | ---- | 64.15%76.6M | ---- | -0.40%123.43M | ---- | -29.12%46.67M | ---- | 77.95%123.93M | ---- |
Financing cost | -28.27%-996.8M | -851.63%-485.56M | -28.28%-486.91M | 0.25%-201.72M | 6.51%-777.11M | 111.00%64.6M | 9.15%-379.57M | -54.58%-202.23M | 10.08%-831.26M | 26.97%-587.37M |
Share of profits of associates | -37.99%178.31M | ---- | -56.89%73.95M | ---- | -22.91%287.56M | ---- | 13.23%171.53M | ---- | 2.21%373M | ---- |
Special items of earning before tax | -96.00%24.99M | -2,675.13%-29.62M | -30.83%227.51M | -575.24%-23.25M | 631.40%624.21M | 121.77%1.15M | 1,230.18%328.9M | 131.97%4.89M | 57.01%-117.47M | -104.25%-5.29M |
Earning before tax | 42.31%4.24B | 19.28%3.15B | 29.74%1.86B | 44.03%636.13M | 173.64%2.98B | 31.80%2.64B | 27.62%1.44B | 42.52%441.68M | -67.75%1.09B | -24.27%2B |
Tax | -99.11%-960.24M | -32.02%-689.31M | -25.38%-406.41M | -32.63%-179.76M | 37.16%-482.28M | 3.34%-522.14M | -2.45%-324.16M | -7.79%-135.53M | -16.21%-767.5M | -13.07%-540.18M |
After-tax profit from continuing operations | 31.35%3.28B | 16.14%2.46B | 31.01%1.46B | 49.07%456.37M | 676.03%2.5B | 44.77%2.12B | 37.46%1.11B | 66.24%306.14M | -88.15%322.05M | -32.50%1.46B |
After-tax profit from non-continuing business | ---- | --0 | ---- | --0 | ---- | --0 | ---- | --0 | ---- | --0 |
Earning after tax | 31.35%3.28B | 16.14%2.46B | 31.01%1.46B | 49.07%456.37M | 676.03%2.5B | 44.77%2.12B | 37.46%1.11B | 66.24%306.14M | -88.15%322.05M | -32.50%1.46B |
Minority profit | 91.72%269.37M | 272.20%186.22M | 1,897.01%117.03M | 2,164.43%52.28M | 1,483.36%140.51M | 387.50%50.03M | -17.15%5.86M | -21.33%2.31M | -41.34%8.87M | -18.13%10.26M |
Profit attributable to shareholders | 27.75%3.01B | 9.94%2.27B | 21.12%1.34B | 33.00%404.09M | 653.15%2.36B | 42.35%2.07B | 37.95%1.11B | 67.66%303.84M | -88.41%313.18M | -32.58%1.45B |
Basic earnings per share | 27.76%0.6315 | 11.63%0.48 | 21.10%0.2806 | 32.97%0.0847 | 653.51%0.4943 | 43.33%0.43 | 37.92%0.2317 | 67.63%0.0637 | -88.42%0.0656 | -33.33%0.3 |
Diluted earnings per share | 27.76%0.6315 | 653.51%0.4943 | -88.42%0.0656 | |||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) |
Audit Opinions | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- |
Auditor | Ernst & Young (Special General Partnership), Ernst & Young | -- | -- | -- | Ernst & Young (Special General Partnership), Ernst & Young | -- | -- | -- | Ernst & Young (Special General Partnership), Ernst & Young | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data